vs
BADGER METER INC（BMI）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
BADGER METER INC的季度营收约是REPLIGEN CORP的1.2倍（$234.1M vs $197.9M），BADGER METER INC净利率更高（14.3% vs 6.7%，领先7.6%），BADGER METER INC同比增速更快（14.1% vs 13.6%），BADGER METER INC自由现金流更多（$50.8M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 9.2%）
Badger Meter Inc是全球领先的流量测量与控制解决方案供应商，主要服务水务企业、工业、商业及住宅客户群体，核心产品包括智能水表、物联网使用监测系统及配套软件，可帮助客户追踪资源消耗、减少浪费、提升运营效率，核心市场覆盖北美、欧洲及亚太地区。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BMI vs RGEN — 直观对比
营收规模更大
BMI
是对方的1.2倍
$197.9M
营收增速更快
BMI
高出0.5%
13.6%
净利率更高
BMI
高出7.6%
6.7%
自由现金流更多
BMI
多$33.2M
$17.6M
两年增速更快
RGEN
近两年复合增速
9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $234.1M | $197.9M |
| 净利润 | $33.6M | $13.3M |
| 毛利率 | 39.7% | 52.5% |
| 营业利润率 | 18.4% | 9.0% |
| 净利率 | 14.3% | 6.7% |
| 营收同比 | 14.1% | 13.6% |
| 净利润同比 | 9.3% | 143.9% |
| 每股收益（稀释后） | $1.13 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BMIRGEN
| Q4 25 | $234.1M | $197.9M | ||
| Q3 25 | $222.2M | $188.8M | ||
| Q2 25 | $238.1M | $182.4M | ||
| Q1 25 | $222.2M | $169.2M | ||
| Q4 24 | $205.2M | $174.1M | ||
| Q3 24 | $208.4M | $154.9M | ||
| Q2 24 | $216.7M | $154.1M | ||
| Q1 24 | $196.3M | $151.3M |
净利润BMIRGEN
| Q4 25 | $33.6M | $13.3M | ||
| Q3 25 | $35.1M | $14.9M | ||
| Q2 25 | $34.6M | $14.9M | ||
| Q1 25 | $38.4M | $5.8M | ||
| Q4 24 | $30.7M | $-30.3M | ||
| Q3 24 | $32.0M | $-654.0K | ||
| Q2 24 | $33.1M | $3.3M | ||
| Q1 24 | $29.1M | $2.1M |
毛利率BMIRGEN
| Q4 25 | 39.7% | 52.5% | ||
| Q3 25 | 43.1% | 53.2% | ||
| Q2 25 | 41.1% | 50.0% | ||
| Q1 25 | 42.9% | 53.6% | ||
| Q4 24 | 40.3% | 26.1% | ||
| Q3 24 | 40.2% | 50.0% | ||
| Q2 24 | 39.4% | 49.8% | ||
| Q1 24 | 39.3% | 49.5% |
营业利润率BMIRGEN
| Q4 25 | 18.4% | 9.0% | ||
| Q3 25 | 20.7% | 8.9% | ||
| Q2 25 | 18.8% | 7.6% | ||
| Q1 25 | 22.2% | 3.9% | ||
| Q4 24 | 19.1% | -17.7% | ||
| Q3 24 | 19.5% | -5.1% | ||
| Q2 24 | 19.2% | 1.0% | ||
| Q1 24 | 18.6% | 1.3% |
净利率BMIRGEN
| Q4 25 | 14.3% | 6.7% | ||
| Q3 25 | 15.8% | 7.9% | ||
| Q2 25 | 14.5% | 8.2% | ||
| Q1 25 | 17.3% | 3.4% | ||
| Q4 24 | 15.0% | -17.4% | ||
| Q3 24 | 15.4% | -0.4% | ||
| Q2 24 | 15.3% | 2.2% | ||
| Q1 24 | 14.8% | 1.4% |
每股收益（稀释后）BMIRGEN
| Q4 25 | $1.13 | $0.24 | ||
| Q3 25 | $1.19 | $0.26 | ||
| Q2 25 | $1.17 | $0.26 | ||
| Q1 25 | $1.30 | $0.10 | ||
| Q4 24 | $1.04 | $-0.55 | ||
| Q3 24 | $1.08 | $-0.01 | ||
| Q2 24 | $1.12 | $0.06 | ||
| Q1 24 | $0.99 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $713.3M | $2.1B |
| 总资产 | $973.6M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BMIRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务BMIRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BMIRGEN
| Q4 25 | $713.3M | $2.1B | ||
| Q3 25 | $702.5M | $2.1B | ||
| Q2 25 | $677.6M | $2.1B | ||
| Q1 25 | $641.7M | $2.0B | ||
| Q4 24 | $606.2M | $2.0B | ||
| Q3 24 | $591.2M | $2.0B | ||
| Q2 24 | $563.1M | $2.0B | ||
| Q1 24 | $535.6M | $2.0B |
总资产BMIRGEN
| Q4 25 | $973.6M | $2.9B | ||
| Q3 25 | $978.3M | $2.9B | ||
| Q2 25 | $936.4M | $2.9B | ||
| Q1 25 | $899.6M | $2.9B | ||
| Q4 24 | $816.4M | $2.8B | ||
| Q3 24 | $802.9M | $2.8B | ||
| Q2 24 | $781.3M | $2.9B | ||
| Q1 24 | $743.5M | $2.8B |
负债/权益比BMIRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $54.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $50.8M | $17.6M |
| 自由现金流率自由现金流/营收 | 21.7% | 8.9% |
| 资本支出强度资本支出/营收 | 1.7% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.63× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $169.7M | $93.9M |
8季度趋势，按日历期对齐
经营现金流BMIRGEN
| Q4 25 | $54.8M | $25.7M | ||
| Q3 25 | $51.3M | $48.1M | ||
| Q2 25 | $44.6M | $28.6M | ||
| Q1 25 | $33.0M | $15.0M | ||
| Q4 24 | $52.1M | $39.2M | ||
| Q3 24 | $45.1M | $49.3M | ||
| Q2 24 | $36.4M | $42.2M | ||
| Q1 24 | $21.5M | $44.7M |
自由现金流BMIRGEN
| Q4 25 | $50.8M | $17.6M | ||
| Q3 25 | $48.2M | $43.4M | ||
| Q2 25 | $40.6M | $21.5M | ||
| Q1 25 | $30.1M | $11.4M | ||
| Q4 24 | $47.4M | $33.6M | ||
| Q3 24 | $42.0M | $42.3M | ||
| Q2 24 | $34.1M | $37.4M | ||
| Q1 24 | $18.8M | $36.4M |
自由现金流率BMIRGEN
| Q4 25 | 21.7% | 8.9% | ||
| Q3 25 | 21.7% | 23.0% | ||
| Q2 25 | 17.1% | 11.8% | ||
| Q1 25 | 13.5% | 6.8% | ||
| Q4 24 | 23.1% | 19.3% | ||
| Q3 24 | 20.1% | 27.3% | ||
| Q2 24 | 15.7% | 24.3% | ||
| Q1 24 | 9.6% | 24.0% |
资本支出强度BMIRGEN
| Q4 25 | 1.7% | 4.1% | ||
| Q3 25 | 1.4% | 2.5% | ||
| Q2 25 | 1.7% | 3.9% | ||
| Q1 25 | 1.3% | 2.1% | ||
| Q4 24 | 2.3% | 3.2% | ||
| Q3 24 | 1.5% | 4.5% | ||
| Q2 24 | 1.1% | 3.1% | ||
| Q1 24 | 1.4% | 5.5% |
现金转化率BMIRGEN
| Q4 25 | 1.63× | 1.93× | ||
| Q3 25 | 1.46× | 3.23× | ||
| Q2 25 | 1.29× | 1.92× | ||
| Q1 25 | 0.86× | 2.57× | ||
| Q4 24 | 1.70× | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 1.10× | 12.70× | ||
| Q1 24 | 0.74× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BMI
| Transferred At Point In Time | $198.6M | 85% |
| Transferred Over Time | $22.1M | 9% |
| Other | $13.4M | 6% |
RGEN
暂无分部数据
